Skip to main content
Organigram Global Inc. (OGI)
NASDAQ: OGI · Real-Time Price · USD
1.600
+0.010 (0.63%)
At close: Aug 13, 2025, 4:00 PM
1.609
+0.009 (0.57%)
After-hours: Aug 13, 2025, 6:49 PM EDT

Organigram Global Revenue

Organigram Global had revenue of 70.79M CAD in the quarter ending June 30, 2025, with 72.41% growth. This brings the company's revenue in the last twelve months to 223.82M, up 50.01% year-over-year. In the fiscal year ending September 30, 2024, Organigram Global had annual revenue of 159.84M with 7.13% growth.

Revenue (ttm)
223.82M CAD
Revenue Growth
+50.01%
P/S Ratio
1.31
Revenue / Employee
249,243 CAD
Employees
898
Market Cap
214.91M USD

Revenue Chart

* This company reports financials in CAD.

History

Fiscal Year End Revenue Change Growth
Sep 30, 2024159.84M10.64M7.13%
Sep 30, 2023149.21M3.40M2.33%
Aug 31, 2022145.81M66.65M84.19%
Aug 31, 202179.16M-7.63M-8.79%
Aug 31, 202086.80M6.38M7.94%
Aug 31, 2019 Pro Pro Pro
Aug 31, 2018 Pro Pro Pro
Aug 31, 2017 Pro Pro Pro
Aug 31, 2016 Pro Pro Pro
Aug 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 422.82B
Johnson & Johnson 90.63B
Merck & Co. 63.62B
AbbVie 58.33B
AstraZeneca 56.50B
Novartis AG 55.19B
Eli Lilly and Company 53.26B
Novo Nordisk 49.11B
Revenue Rankings

OGI News

More News